Trial Profile
Focal type in-stent restenosis after drug-eluting stent implantation treated by cutting balloon angioplasty versus sirolimus-eluting stent.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Aug 2012
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms FOCUS
- 07 Aug 2012 Actual end date (1 Mar 2011) added as reported by ClinicalTrials.gov record.
- 01 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 06 Aug 2007 New trial record.